已收录 273496 条政策
 政策提纲
  • 暂无提纲
Serum levels of 25-hydroxyvitamin D and IL17A and their association with acne severity in patients with severe and very severe acne vulgaris
[摘要] Background  Vitamin D deficiency and interleukin-17 (IL17) excess production have been detected in many inflammatory skin diseases. Acne vulgaris is a well-known inflammatory skin disease for which numerous treatment guidelines have been published, with limited success in several situations. Objective  To evaluate the association between 25-hydroxyvitamin D [25 (OH) D] and IL17 levels from the patients’ serum and acne vulgaris. To determine the therapeutic effect of vitamin D supplementation on severe acne. Patients and methods  This case–control study was conducted on 30 patients with severe and very severe acne vulgaris. The severity of the disease was determined by Global acne grading system (GAGS). Moreover, 15 controls were recruited. Serum levels of 25 (OH) D and IL17A were measured at the baseline in all studied participants. After that, the patients with acne with detected vitamin D hypovitaminosis were given an oral dose of 4000 IU cholecalciferol daily for 3 months, and in this selected group, serum 25 (OH) D and IL17A levels along with GAGS score were measured again at the end of the treatment. Results  The mean serum concentration of 25 (OH) D and IL17A in patients with severe acne was statistically different from the controls. Acne severity was negatively correlated with the vitamin D serum level and positively correlated with the IL17A serum level. After supplementation, significant improvement of both the median GAGS score and IL17A serum level was found. Conclusion  Vitamin D deficiency might be related to the severity of acne vulgaris, and its supplementation may help ameliorate inflammatory lesions of severe acne through its immunomodulatory effect.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 皮肤病学
[关键词] acne;interleukin-17;vitamin D [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文